Report error Found 100  Enz. Inhib. hit(s) with all data for entry = 50007898  
Affinity DataKi:  0.300nMAssay Description:Inhibition of trypsinMore data for this Ligand-Target Pair
Affinity DataKi:  2.30nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  3.5nMAssay Description:Inhibition against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi:  3.5nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  5.5nMAssay Description:Inhibition against human coagulation factor XaMore data for this Ligand-Target Pair
Affinity DataKi:  8.60nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  8.70nMAssay Description:Inhibition against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi:  36nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  41nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  85nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  85nMAssay Description:Inhibition against human coagulation factor XaMore data for this Ligand-Target Pair
Affinity DataKi:  150nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  1.30E+3nMAssay Description:Concentration necessary to double the time required for clot formation induced by the addition of 4 NIH u/mL(final concentration) bovine thrombin.More data for this Ligand-Target Pair
Affinity DataKi:  1.50E+3nMAssay Description:Inhibition against human Coagulation factor VIIMore data for this Ligand-Target Pair
Affinity DataKi:  1.60E+3nMAssay Description:Inhibition against human coagulation factor XaMore data for this Ligand-Target Pair
 
 	
























